In a recent interview with Agrify, they spoke with Front Range Biosciences' Co-founder and CEO, Dr. Jonathan Vaught, who discusses how cultivation innovations are paving the way for a brighter, more successful future in cannabis and beyond. Read an excerpt from the article:
"Front Range Bioscience is trying to capture insights that allow informed decisions about how to develop new products.
"The clean stock program starts with germplasm, also known as seeds, to breed and screen to look deep into the chemistry of plants. They go a layer beyond cannabinoids and terpenes to assemble a diverse collection, such as flavonoids, that they believe will have positive [impact on] human health in the future."
Read the full article here.